Latest Breaking News On - Theranostic platform - Page 1 : comparemela.com

Curasight A/S reports positive preclinical results with uTREAT[®] in lung cancer (NSCLC)

Preclinical studies show uTREAT® effective in treating non-small cell lung cancer Data follows recent announcement of positive preclinical results within glioblastoma and supports hypothesis.

Ulrich krasilnikoffCurasightas curasightPositron emissions tomographyRadioligand therapyTheranostic platform

Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments

Q2 2023 DANYELZA® record net product revenues of $20.8 million, driving YoY growth of 112% and a 3% sequential increase compared to Q1 2023Managem.

United statesCourtney duganCompany selfBrazilian health regulatory agencyAmerican association for cancer researchCompany annual report on formMemorial sloan kettering cancer centerY mabs therapeutics incSciclone pharmaceuticalsAmerican society of clinical oncologySecurities exchangeGlobe newswirey mabs therapeutics incCompany quarterly report on formAbs therapeuticsThomas gadInterim chief executive

Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments

Y-mAbs Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

United statesCourtney duganAmerican society of clinical oncologySciclone pharmaceuticalsCompany selfCompany annual report on formCompany quarterly report on formMemorial sloan kettering cancer centerSecurities exchangeGlobe newswirey mabs therapeutics incBrazilian health regulatory agencyY mabs therapeutics incAmerican association for cancer researchAbs therapeuticsThomas gadInterim chief executive

Y-mAbs Announces Presentation of GD2-SADA Study at ASCO

NEW YORK, May 26, 2023 Y-mAbs Therapeutics, Inc. a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for. | May 26, 2023

New yorkUnited statesMemorial sloan kettering cancer centerCourtney duganMassachusetts institute of technologyAmerican society of clinical oncologyY mabs therapeutics incCompany selfGlobenewswire incAbs therapeuticsTheranostic platformClinical oncologyAnnual meetingSloan kettering cancer centerPrivate securities litigation reform actAnnual report